Development of Pyrazolo[3,4-d]pyrimidine Kinase Inhibitors as Potential Clinical Candidates for Glioblastoma Multiforme. (2020)
Attributed to:
Radiotherapy activated materials for enhanced cancer treatments
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acsmedchemlett.9b00530
PubMed Identifier: 32435367
Publication URI: http://europepmc.org/abstract/MED/32435367
Type: Journal Article/Review
Volume: 11
Parent Publication: ACS medicinal chemistry letters
Issue: 5
ISSN: 1948-5875